Nominet has terminated its recently appointed chief commercial officer, Jill Finney, who was today alleged to have been involved in the “cover-up” of baby deaths at a British hospital.
The allegations concern Finney’s previous job as deputy CEO of the Care Quality Commission, which regulates the UK’s National Health Service.
According to reports today, Finney was one of three people responsible for suppressing an internal CQC report detailing its own failure to spot problems at a maternity unit.
Poor standards of care at the hospital in question led to the deaths of as many as 16 babies and two mothers, the Guardian reported today.
It’s a big story in the UK, where a tendency for NHS executives to put the reputations of their hospitals over transparency and patient care has become a political football.
In a statement, Nominet, which regularly faces its own complaints about transparency and accountability, said:
The increasing public scrutiny over our CCO’s former role at CQC has made it impossible for her to continue with her role and responsibilities at Nominet.
With regret, we felt it necessary to terminate Jill Finney’s employment with immediate effect. Ms Finney will be paid one month’s salary in lieu of notice.
Finney joined Nominet directly from the CQC in February. Her name had been associated with transparency failures at the CQC even then, which made the hire seem odd at the time.